175 related articles for article (PubMed ID: 8201222)
1. PreS1 antigen/antibody patterns following interferon therapy in acute and chronic hepatitis B.
Petit MA; Zoulim F; Berthillon P; Capel F; Li J; Dauguet C; Ferrari C; Trépo C
J Hepatol; 1994 Jan; 20(1):47-56. PubMed ID: 8201222
[TBL] [Abstract][Full Text] [Related]
2. PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.
Petit MA; Capel F; Zoulim F; Dubanchet S; Chemin I; Penna A; Ferrari C; Trépo C
Arch Virol Suppl; 1992; 4():105-12. PubMed ID: 1280500
[TBL] [Abstract][Full Text] [Related]
3. [The clinical significance of PreS1Ag and anti-PreS1 in patients with chronic hepatitis B].
Zhang XD; Ren S; Yu HB; Liu YL; Jin Y; Huang YX; Chen JM; Chen XY
Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):674-7. PubMed ID: 22152382
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of IgM antibodies towards an immunodominant B-cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone/interferon alpha 2b treatment of chronic hepatitis B virus infection.
Fei GZ; Sylvan SP; Hellström UB; Yao GB
J Med Virol; 1995 Jun; 46(2):138-43. PubMed ID: 7636501
[TBL] [Abstract][Full Text] [Related]
5. The clinical and epidemiological significance of serum PreS1/anti-PreS1 in HBV infection.
Mi Z; Feng F; Zhang X; Lian Z; Wang H; Tong Y
Chin Med J (Engl); 1999 Apr; 112(4):321-4. PubMed ID: 11593530
[TBL] [Abstract][Full Text] [Related]
6. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.
Mimms LT; Floreani M; Tyner J; Whitters E; Rosenlof R; Wray L; Goetze A; Sarin V; Eble K
Virology; 1990 Jun; 176(2):604-19. PubMed ID: 1693248
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of an association between detection of IgG antibody reactivity towards the C-terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B.
Hellström U; Lindh M; Krogsgaard K; Sylvan S
J Gastroenterol Hepatol; 2008 May; 23(5):804-10. PubMed ID: 17931371
[TBL] [Abstract][Full Text] [Related]
8. Significance and relevance of serum preS1 antigen detection in wild-type and variant hepatitis B virus (HBV) infections.
Petit MA; Capel F; Gerken G; Dubanchet S; Bréchot C; Trépo C
Arch Virol Suppl; 1993; 8():179-87. PubMed ID: 8260863
[TBL] [Abstract][Full Text] [Related]
9. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment.
Günther S; Meisel H; Reip A; Miska S; Krüger DH; Will H
Virology; 1992 Mar; 187(1):271-9. PubMed ID: 1736529
[TBL] [Abstract][Full Text] [Related]
10. Detection of IgM, IgA, and IgG antibodies to preS2 antigen in hepatitis B virus infection.
Suga M; Arima K; Yachi A
Digestion; 1991; 50(3-4):153-61. PubMed ID: 1812042
[TBL] [Abstract][Full Text] [Related]
11. Detection of proteins encoded by the pre-S region of hepatitis B virus in the sera of HBsAg carriers: relation to viral replication.
Ibarra MZ; Mora I; Bartolomé J; Porres JC; Carreño V
Liver; 1989 Jun; 9(3):153-8. PubMed ID: 2747440
[TBL] [Abstract][Full Text] [Related]
12. Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication.
Petit MA; Zoulim F; Capel F; Dubanchet S; Dauguet C; Trepo C
Hepatology; 1990 May; 11(5):809-14. PubMed ID: 2347555
[TBL] [Abstract][Full Text] [Related]
13. Antibody responses to preS components after immunization of children with low doses of BioHepB.
Madalinski K; Sylvan SP; Hellström U; Mikolajewicz J; Zembrzuska-Sadkowska E; Piontek E
Vaccine; 2001 Oct; 20(1-2):92-7. PubMed ID: 11567751
[TBL] [Abstract][Full Text] [Related]
14. Detection of anti-preS1 antibodies for recovery of hepatitis B patients by immunoassay.
Wei J; Wang YQ; Lu ZM; Li GD; Wang Y; Zhang ZC
World J Gastroenterol; 2002 Apr; 8(2):276-81. PubMed ID: 11925607
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical structure of the hepatitis B surface antigen vaccine--II. Analysis of antibody responses in human sera against the envelope proteins.
Petit MA; Maillard P; Capel F; Pillot J
Mol Immunol; 1986 May; 23(5):511-23. PubMed ID: 3748012
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.
Kohno H; Inoue T; Tsuda F; Okamoto H; Akahane Y
J Gen Virol; 1996 Aug; 77 ( Pt 8)():1825-31. PubMed ID: 8760433
[TBL] [Abstract][Full Text] [Related]
18. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
[TBL] [Abstract][Full Text] [Related]
19. Correlation of preS antigens and clinical status during chronic hepatitis B virus infection.
Taliani G; Rapicetta M; Francisci D; Xiang J; Sarrecchia B; De Bac C; Stagni G
Med Microbiol Immunol; 1991; 180(5):239-48. PubMed ID: 1762604
[TBL] [Abstract][Full Text] [Related]
20. IgM anti-preS2 monitoring during combined corticosteroid/interferon-alpha 2b therapy in chronic hepatitis B.
Fei GZ; Sylvan SP; Hellström UB; Yao GB
Liver; 1991 Dec; 11(6):358-64. PubMed ID: 1779715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
